8-K filing — Inhibikase Therapeutics, Inc. (IKT)
Filed: 2026-09-08 AccNo: 0001193125-26-385293 Size: 4 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
News
Source-attributed headlines with timestamps and links to the companies and crypto markets they mention.
Latest Coverage
30 headlines
Filed: 2026-09-08 AccNo: 0001193125-26-385293 Size: 4 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Goldman says Tesla’s Cybercab could cost up to 30 cents less per mile than rivals, though traders doubt Musk hits his $30,000 target.
Filed: 2026-09-08 AccNo: 0001104659-26-105931 Size: 267 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Filed: 2026-09-08 AccNo: 0001111928-26-000169 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits
Filed: 2026-09-08 AccNo: 0001104659-26-105930 Size: 272 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Filed: 2026-09-08 AccNo: 0000714395-26-000039 Size: 3 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Filed: 2026-09-08 AccNo: 0000796343-26-000144 Size: 187 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Filed: 2026-09-08 AccNo: 0001104659-26-105928 Size: 142 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Filed: 2026-09-08 AccNo: 0000776901-26-000140 Size: 6 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Filed: 2026-09-08 AccNo: 0001104659-26-105925 Size: 206 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and Exhibits
Coherent (NYSE:COHR) has outperformed the market over the past 15 years by 7.17% on an annualized basis producing an average annual return of 20.36%. Currently, Coherent has a market capitalization of $59.17 billion.
Filed: 2026-09-08 AccNo: 0001193125-26-385271 Size: 143 KB Item 3.02: Unregistered Sales of Equity Securities Item 8.01: Other Events
Filed: 2026-09-08 AccNo: 0001193125-26-385270 Size: 163 KB Item 3.02: Unregistered Sales of Equity Securities
Filed: 2026-09-08 AccNo: 0001628280-26-060928 Size: 138 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits
Filed: 2026-09-08 AccNo: 0000056679-26-000023 Size: 160 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Filed: 2026-09-08 AccNo: 0000891482-26-000040 Size: 237 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits
Filed: 2026-09-08 AccNo: 0001101215-26-000081 Size: 44 MB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits
Filed: 2026-09-08 AccNo: 0002050260-26-000051 Size: 134 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Filed: 2026-09-08 AccNo: 0000897077-26-000101 Size: 138 KB Item 2.05: Cost Associated with Exit or Disposal Activities Item 2.06: Material Impairments